SK287244B6 - Farmaceutický kit na terapiu infertility a jeho použitie - Google Patents

Farmaceutický kit na terapiu infertility a jeho použitie Download PDF

Info

Publication number
SK287244B6
SK287244B6 SK1384-2001A SK13842001A SK287244B6 SK 287244 B6 SK287244 B6 SK 287244B6 SK 13842001 A SK13842001 A SK 13842001A SK 287244 B6 SK287244 B6 SK 287244B6
Authority
SK
Slovakia
Prior art keywords
pharmaceutical kit
programming
kit according
lhrh
progestogen
Prior art date
Application number
SK1384-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK13842001A3 (sk
Inventor
J�Rgen Engel
Hilde Riethm�Ller-Winzen
Original Assignee
Zentaris Ivf Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Ivf Gmbh filed Critical Zentaris Ivf Gmbh
Publication of SK13842001A3 publication Critical patent/SK13842001A3/sk
Publication of SK287244B6 publication Critical patent/SK287244B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK1384-2001A 1999-03-31 2000-03-21 Farmaceutický kit na terapiu infertility a jeho použitie SK287244B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12724199P 1999-03-31 1999-03-31
US13163299P 1999-04-28 1999-04-28
PCT/EP2000/002466 WO2000059542A1 (en) 1999-03-31 2000-03-21 Method for a programmed controlled ovarian stimulation protocol

Publications (2)

Publication Number Publication Date
SK13842001A3 SK13842001A3 (sk) 2002-09-10
SK287244B6 true SK287244B6 (sk) 2010-04-07

Family

ID=26825471

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1384-2001A SK287244B6 (sk) 1999-03-31 2000-03-21 Farmaceutický kit na terapiu infertility a jeho použitie

Country Status (28)

Country Link
US (1) US8173592B1 (ja)
EP (1) EP1165138B1 (ja)
JP (1) JP4616999B2 (ja)
KR (1) KR100679880B1 (ja)
CN (1) CN1346281B (ja)
AR (1) AR023249A1 (ja)
AT (1) ATE265862T1 (ja)
AU (1) AU768544B2 (ja)
BG (1) BG65270B1 (ja)
BR (1) BR0009477A (ja)
CA (1) CA2367214C (ja)
CO (1) CO4970741A1 (ja)
CZ (1) CZ299820B6 (ja)
DE (1) DE60010452T2 (ja)
DK (1) DK1165138T3 (ja)
ES (1) ES2219331T3 (ja)
HK (1) HK1044892B (ja)
HU (1) HU229252B1 (ja)
IL (2) IL145630A0 (ja)
MX (1) MXPA01009862A (ja)
NO (1) NO327210B1 (ja)
NZ (1) NZ514964A (ja)
PL (1) PL199569B1 (ja)
PT (1) PT1165138E (ja)
RU (1) RU2226395C2 (ja)
SK (1) SK287244B6 (ja)
TW (1) TWI241194B (ja)
WO (1) WO2000059542A1 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0788799A3 (en) 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagonists in the treatment of fertility disorders
EA008098B1 (ru) * 2003-02-21 2007-02-27 Шеринг Акциенгезельшафт Стойкий к уф-излучению трансдермальный пластырь
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
US8962013B2 (en) * 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
EP1719504A1 (de) * 2005-05-02 2006-11-08 Schering AG Festes transdermales therapeutisches System mit UV-Absorber
AU2006270749B2 (en) * 2005-07-22 2013-02-07 Takeda Pharmaceutical Company Limited Premature ovulation preventive agent
WO2014072350A1 (en) * 2012-11-09 2014-05-15 Iasomai Ab N-acetyl-l-cysteine for use in in vitro fertilization
WO2016044271A2 (en) 2014-09-15 2016-03-24 Children's Medical Center Corporation Methods and compositions to increase somatic cell nuclear transfer (scnt) efficiency by removing histone h3-lysine trimethylation
CN107405385A (zh) 2015-04-17 2017-11-28 辉凌公司 用于治疗不育的组合物
AU2017336338B2 (en) * 2016-09-30 2022-11-10 Sumitomo Pharma Switzerland Gmbh Methods of treating female infertility
RU2665967C1 (ru) * 2017-06-14 2018-09-05 Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) Способ стимуляции роста фолликулов в программах экстракорпорального оплодотворения у пациенток с бесплодием различного генеза и "бедным ответом на стимуляцию"
CN107982520A (zh) * 2017-12-25 2018-05-04 上海交通大学医学院附属第九人民医院 外源性MPA与hMG在制备动物模型药物中的应用
CN110570952B (zh) * 2018-06-05 2022-04-12 北京大学第三医院 预测拮抗剂方案下受试者卵巢低反应概率的系统及指导促性腺激素起始用药剂量选择的系统
CN110491505B (zh) * 2019-08-22 2021-06-01 北京大学第三医院（北京大学第三临床医学院） 预测受试者卵巢刺激过程中获得的卵母细胞数量的系统
CN113456801A (zh) * 2021-08-05 2021-10-01 浙江大学医学院附属第四医院 人绒毛膜促性腺激素在制备早发性卵巢功能不全患者的助孕药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016259A (en) * 1974-07-26 1977-04-05 Research Corporation Contraceptive polypeptides
ATE65407T1 (de) * 1984-04-03 1991-08-15 Serono Lab Verfahren zur herbeifuehrung der ovulation.
HU221589B (hu) 1989-03-10 2002-11-28 Endorecherche Inc. Emlő- és méhrák kezelésére alkalmas kombinációs gyógyszerkészítmény és eljárás előállítására
US5470847A (en) * 1993-12-10 1995-11-28 Board Of Regents, The University Of Texas System Ovulation control by regulating nitric oxide levels with arginine derivatives
AU691952B2 (en) 1994-07-22 1998-05-28 Eastern Virginia Medical School Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
EP0788799A3 (en) * 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagonists in the treatment of fertility disorders
US5945128A (en) * 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
CA2200541C (en) 1997-01-22 2013-02-19 Philippe Bouchard Lhrh-antagonists in the treatment of fertility disorders
AU4325797A (en) * 1997-06-23 1999-01-04 Mcneil-Ppc, Inc. Acetaminophen and cisapride analgesics
EP1082129B1 (en) * 1998-04-23 2003-10-29 Zentaris AG Method for the treatment of fertility disorders

Also Published As

Publication number Publication date
AR023249A1 (es) 2002-09-04
EP1165138A1 (en) 2002-01-02
NO327210B1 (no) 2009-05-11
KR20010105401A (ko) 2001-11-28
WO2000059542A9 (en) 2001-11-22
ATE265862T1 (de) 2004-05-15
CZ299820B6 (cs) 2008-12-03
PL199569B1 (pl) 2008-10-31
KR100679880B1 (ko) 2007-02-07
MXPA01009862A (es) 2003-10-14
JP2002541122A (ja) 2002-12-03
NO20014736D0 (no) 2001-09-28
ES2219331T3 (es) 2004-12-01
US8173592B1 (en) 2012-05-08
TWI241194B (en) 2005-10-11
IL145630A (en) 2009-09-01
AU768544B2 (en) 2003-12-18
HUP0200431A2 (hu) 2002-07-29
EP1165138B1 (en) 2004-05-06
BG106045A (en) 2002-05-31
AU4106900A (en) 2000-10-23
HUP0200431A3 (en) 2004-04-28
CN1346281B (zh) 2010-04-14
NO20014736L (no) 2001-11-26
CA2367214A1 (en) 2000-10-12
BG65270B1 (bg) 2007-11-30
JP4616999B2 (ja) 2011-01-19
CO4970741A1 (es) 2000-11-07
CZ20013495A3 (cs) 2002-06-12
PT1165138E (pt) 2004-09-30
RU2226395C2 (ru) 2004-04-10
CA2367214C (en) 2008-07-29
WO2000059542A1 (en) 2000-10-12
DK1165138T3 (da) 2004-08-30
HK1044892B (zh) 2011-06-30
BR0009477A (pt) 2002-01-08
SK13842001A3 (sk) 2002-09-10
IL145630A0 (en) 2002-06-30
DE60010452T2 (de) 2005-04-14
HK1044892A1 (en) 2002-11-08
CN1346281A (zh) 2002-04-24
DE60010452D1 (de) 2004-06-09
HU229252B1 (en) 2013-10-28
PL351327A1 (en) 2003-04-07
NZ514964A (en) 2003-08-29

Similar Documents

Publication Publication Date Title
Fedele et al. Superovulation with human menopausal gonadotropins in the treatment of infertility associated with minimal or mild endometriosis: a controlled randomized study
SK287244B6 (sk) Farmaceutický kit na terapiu infertility a jeho použitie
Sauer et al. Comparative efficacy and safety of cetrorelix with or without mid-cycle recombinant LH and leuprolide acetate for inhibition of premature LH surges in assisted reproduction
Balasch et al. Triggering of ovulation by a gonadotropin releasing hormone agonist in gonadotropin-stimulated cycles for prevention of ovarian hyperstimulation syndrome and multiple pregnancy
JP2002541122A5 (ja)
Roulier et al. Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment
AU2003274929B2 (en) Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method
JP2003520823A5 (ja)
Huang et al. Two different timings of intrauterine insemination for non-male infertility
KARLSTRÖM et al. Addition of gonadotrophin-releasing hormone agonist and/or two inseminations with husband's sperm do not improve the pregnancy rate in superovulated cycles
Meldrum et al. A pilot study to assess oral contraceptive (OC) pretreatment in women undergoing controlled ovarian hyperstimulation (COH) in ganirelix acetate cycles
Simon et al. High doses of gonadotropins have no detrimental effect on in vitro fertilization outcome in normal responders
EP1364658A1 (en) Use of varying ratios of gonadotrophins in controlled ovarian hyperstimulation
Trevisi et al. Clomiphene Citrate in Poor Responder Patients Undergoing an ART: An Alternative to Gonadotropin?
Olivennes Gonadotropin-Releasing Hormone-Antagonist in Human In Vitro Fertilization
Andrade et al. Comparison of 150 IU and 225 IU of Follitropin-β in a Fixed-dose Regimen for Ovarian Stimulation Using a Depot Formulation of GnRH Agonist: a prospective randomized clinical trial.
UA72513C2 (en) Pharmacological means for treating infertility by programming of controlled ovarian stimulation and assisted reproductive procedures

Legal Events

Date Code Title Description
MK4A Expiry of patent

Expiry date: 20200321